
Magle Chemoswed Holding Investor Relations Material
Latest events

Q2 2025
1 Aug, 2025

Q1 2025
22 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Magle Chemoswed Holding
Access all reports
Magle Chemoswed Holding AB is a company active in the pharmaceutical and medical device industries, serving as a contract development and manufacturing organization (CDMO). The company is dedicated to offering a wide range of services from development through manufacturing on a contract basis, excelling in bringing innovations from idea to product. Magle Chemoswed operates through its subsidiaries, including Magle Chemoswed AB and Adroit Science AB, focusing on the process development and manufacturing of Active Pharmaceutical Ingredients (API) and the development and manufacturing of products in wound care and diagnostics, particularly those based on degradable starch microspheres. Additionally, it provides consultancy in material characterization and solid-phase analysis, mainly targeting pharmaceutical companies. The company is headquartered in Malmö, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
MAGLE
Country
🇸🇪 Sweden